Get the Stockscreener App
346.80
1.87%
-6.62
Pre-market:
345.60
-1.20
-0.35%
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $346.80, with a volume of 1.67M.
It is down -1.87% in the last 24 hours and down -6.15% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$353.42
Open:
$354.85
24h Volume:
1.67M
Relative Volume:
1.06
Market Cap:
$132.37B
Revenue:
$22.60B
Net Income/Loss:
$2.99B
P/E Ratio:
44.69
EPS:
7.76
Net Cash Flow:
$3.49B
1W Performance:
+2.80%
1M Performance:
-6.15%
6M Performance:
-3.39%
1Y Performance:
+2.26%
1-Day Range:
$345.99
$355.39
1-Week Range:
$330.00
$364.40
52-Week Range:
$314.93
$406.19
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
346.80 | 132.37B | 22.60B | 2.99B | 3.49B | 7.76 |
|
ABT
Abbott Laboratories
|
126.22 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
94.23 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
MDT
Medtronic Plc
|
82.37 | 105.64B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.76 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
Fed. Circ. Won't Revive Stryker Unit's Antiseptic Patents - Law360
Federal Circuit Axes Stryker Unit’s Sterilized Wipe Patents - Bloomberg Law News
Stryker Corporation (SYK): A Bull Case Theory - Yahoo Finance
The Zacks Analyst Blog Bank of America, Chevron, Stryker, Value Line and Sypris - Yahoo Finance
Top Analyst Reports for Bank of America, Chevron & Stryker - Yahoo Finance
Stryker (SYK): BTIG Analyst Revises Price Target Amid MedTech Ou - GuruFocus
Meritage Homes, TopBuild, Installed Building Products, Champion Homes, and Stryker Shares Plummet, What You Need To Know - The Globe and Mail
Intramedullary Nail Market size to worth USD 1,537 Million by 2032, says Coherent Market Insights - GlobeNewswire Inc.
What Does the Market Think About Stryker? - Benzinga
Teledyne Technologies Awarded Four-Year, $74 Million US Army Contract to Upgrade Stryker Sensors - MarketScreener
Stryker (SYK): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Stryker (SYK): Buy, Sell, Or Hold Post Q4 Earnings? - Barchart.com
Stryker to announce financial results for its first quarter of fiscal year 2025 - MarketScreener
Mark Your Calendar: Stryker's Q1 2025 Earnings Release Coming May 1 - Stock Titan
Stryker Corporation : INVESTOR ALERTPATIENT SAFETY TECHNOLOGIES, INC. - MarketScreener
Activist shareholder renews push for Stryker to reveal political contributions - Crain's Grand Rapids Business
Stryker, Boston Scientific down as new tariffs impact medtech industry - Seeking Alpha
Pictet Asset Management Holding SA Cuts Stock Position in Stryker Co. (NYSE:SYK) - MarketBeat
Stryker completes sale of U.S. spinal implants business - Ortho Spine News
Evercore ISI Adjusts Stryker Price Target to $400 From $410, Maintains Outperform Rating - MarketScreener
Stryker (SYK): Company Profile, Stock Price, News, Rankings - Fortune
Stryker : 2024 Comprehensive Report - MarketScreener
Stryker Closes Sale of US Spinal Implants Unit to Vascogliosi Brothers - MarketScreener
Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC - Yahoo Finance
Stryker sells US spinal implants business to VB Spine - Investing.com
Stryker Completes Sale Of U.S. Spinal Implants Business - MarketScreener
Stryker Co. (NYSE:SYK) Shares Sold by Franklin Resources Inc. - MarketBeat
Major Strategic Shift: Stryker Sells Spinal Unit While Keeping Key Tech Rights - Stock Titan
Stryker Corporation (NYSE:SYK): One of the Best Robotics Stocks to Buy According to Billionaires - Insider Monkey
Stocks With Rising Relative Strength: Stryker - MSN
California Public Employees Retirement System Raises Stake in Stryker Co. (NYSE:SYK) - MarketBeat
Stryker Corporation (SYK): Jim Cramer Sees Big Gains Despite Tariff Worries - Insider Monkey
Ex-Dividend Reminder: Stryker, Innovative Industrial Properties and Apple Hospitality REIT - Nasdaq
Jim Cramer: Stryker Is A 'Good' Company, Says He Likes This Utilities Stock - Benzinga
Stryker Options Trading: A Deep Dive into Market Sentiment - Benzinga
Stryker increases pay for top execs, reports slightly lower wage for median employee - Medical Design & Outsourcing
Stryker announces intention to nominate Manny Maceda to board of directors - Quantisnow
Stryker nominates new board member - Investing.com
Stryker nominates new board member By Investing.com - Investing.com Canada
Is It Smart To Buy Stryker Corporation (NYSE:SYK) Before It Goes Ex-Dividend? - Yahoo Finance
Stryker announces Annual Meeting of Shareholders - The Globe and Mail
Here's How Much $1000 Invested In Stryker 5 Years Ago Would Be Worth Today - Benzinga
Stryker Makes Shareholder Meeting Accessible: Virtual Format Opens Doors to All Investors - Stock Titan
What's Driving the Market Sentiment Around Stryker? - Benzinga
Breaking Down Stryker: 13 Analysts Share Their Views - Benzinga
Needham maintains Stryker stock Buy rating, $442 target - Investing.com
Spinal Fusion Device Market Forecast Report and Company Analysis 2025-2033 Featuring Medtronic, Stryker, Zimmer Biomet, Orthofix Medical, NuVasive, Globus Medical, Xtant Medical, and Alphatec - Yahoo Finance
New Jersey Rep. Thomas Kean Sold Over $17K Worth of Stryker Stock: Here's What You Should Know - Benzinga
Stryker : 2024 Comprehensive Report Factsheet -March 17, 2025 at 08:10 am EDT - Marketscreener.com
Thomas Kean Jr makes notable trades in Amazon, Magnera Corp, and Stryker Corp - Investing.com Australia
Spelman College Receives $30M To Help Fund New Arts Center - Essence
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.04%
1.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):